Glycomics Market Key Players, Growth rate, Size, Share, Demands, Value and Forecasts to 2028

The global glycomics market was valued at US$1.46 billion in 2022 and is expected to grow to US$3.46 billion in 2028. Glycomics is a subset of glycobiology that involves the systematic study of all glycan structures of a given cell type, tissue, or organism. Glycans, commonly known as polysaccharides, are carbohydrate-based polymers that all living organisms produce. Glycans are crucial macromolecules that provide structure, energy storage, and system regulation. According to their biological sources, glycans are classified as plant, animal, or microbial. Glycomics is a widely emerging scientific field highlighting on defining functional aspects of glycans in biosystems. The use of glycobiology in drug research and development, disease diagnostics, cancer, immunology, and other fields has provided enormous growth prospects for players in the global market. The market is expected to grow at a CAGR of 15.68% over the projected period of 2023-2028.

Get a Free Sample Copy of the Global Glycomics Market Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=6979751

The key players in the global glycomics market are:

Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Waters Corporation, Inc.
Takara Bio, Inc.
Bio Techne, Inc.
Sumitomo Bakelite Co., Ltd.
Merck KGaA
Shimadzu Corporation
AMS Bio
Asparia Glycomics
Lectenz Bio
New England Biolabs

The glycomics market refers to the market for the study and analysis of glycans, which are complex carbohydrates found in cells and tissues. Glycans play a critical role in many biological processes, and their study has important implications for drug discovery, diagnostics, and personalized medicine.

The global glycomics market is expected to grow at a steady pace in the coming years, driven by the increasing demand for personalized medicine and the growing importance of glycans in drug development.

The drug discovery and development segment is expected to be the largest application segment in the glycomics market, driven by the increasing focus on developing glycan-based therapies for various diseases. The diagnostics segment is also expected to contribute to the growth of the market, driven by the increasing use of glycans as biomarkers for disease diagnosis.

The North America region is expected to dominate the global glycomics market, accounting for the largest share of the market in terms of both value and volume. This is primarily due to the presence of a large number of pharmaceutical and biotechnology companies in the region, as well as the increasing focus on personalized medicine and biomarker research. The Asia-Pacific region is also expected to be a significant market for glycomics, driven by the growing biotechnology and pharmaceutical industries in the region.

Direct Purchase of the Global Glycomics Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=6979751

Overall, the global glycomics market is expected to continue growing in the coming years, driven by the increasing demand for personalized medicine and the growing importance of glycans in drug development and disease diagnosis. However, the market could face challenges related to the complexity of glycan analysis and the high cost of glycan analysis technologies.

+ 1 347 333 3771
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.